logo
China is sharing priceless moon samples with international partners, but NASA can't be a part of it

China is sharing priceless moon samples with international partners, but NASA can't be a part of it

Yahoo15-05-2025

When you buy through links on our articles, Future and its syndication partners may earn a commission.
Precious moon samples brought back to Earth by China's Chang'e 5 mission in 2020 have finally been shared with international researchers — but the law has made it difficult for U.S.-based scientists to receive any of the material.
Earlier in May, British planetary scientist Mahesh Anand of the Open University in Milton Keynes travelled to China to "borrow" 60 milligrams (0.002 ounces) of the 1,731-gram (3.8 pounds) Chang'e 5 sample. Scientists from elsewhere in Europe, as well as Ethiopia, Russia and the United States, are also receiving samples.
In the other countries, government funding bodies are paying for the analysis of these loaned samples, but NASA is prevented from funding U.S.-based researchers to do the same. Instead, Timothy Glotch, the lone American planetary scientist who has received a sample of the Chang'e 5 material, had to be funded privately by his own institution, Stony Brook University in New York.
That's because of a law passed in 2011 called the Wolf Amendment. Named after Frank Wolf, the Republican senator who pushed for it, it was inserted as an amendment into the 2011 federal budget and bars bilateral cooperation between NASA (and the scientists the agency funds) and the China National Space Administration (CNSA) and Chinese scientists. The aim is to prevent Chinese government scientists from gaining knowledge of American space technologies that the U.S. government fears could then be used militarily by China against the United States.
The Wolf Amendment seems counter to the old way of doing things. Science has often been a bridge between opposing countries. During the Cold War, the search for extraterrestrial intelligence (SETI) was a project that U.S. and Soviet scientists worked together on, including a famous conference held in the USSR in 1971. Another example was the Apollo–Soyuz rendezvous in 1975, when astronauts and cosmonauts shook hands in space. The Wolf Amendment, however, prevents similar space-science cooperation taking place between the U.S. and Chinese governments without the prior approval of Congress.
And, it seems, the Wolf Amendment works both ways, preventing NASA from receiving or funding research into the Chinese moon samples.
Luckily for Glotch, this has not stopped China from sharing a sample with him and his research group, which includes scientists at San Francisco State University and the University of Hong Kong, as long as they are funded privately. Allowing American researchers access to the Chang'e 5 samples is important, because it allows them to make direct comparisons between Apollo-era lunar samples and the Chang'e 5 samples in the same lab.
Glotch plans to test the thermal properties of his "loaned" sample by heating it (we say loaned, but the analysis will likely destroy the sample), and then comparing it to thermal maps of the moon to provide a greater understanding of the composition of different lunar regions based on how they heat up and cool down in sunlight, relative to the Chang'e 5 sample.
Related stories:
— China's Chang'e 5 capsule lands on Earth with the 1st new moon samples in 44 years
— China returns samples from the moon's far side in historic 1st (video)
— The moon on Earth: Where are NASA's Apollo lunar rocks now?
The Chang'e 5 sample was obtained by the Chinese spacecraft from Mons Rümker, which is an ancient volcanic region in the giant Oceanus Procellarum ("Ocean of Storms"). By making direct comparisons between the Apollo samples, which were taken from various locations on the moon, and the Chang'e 5 sample, Glotch's group hopes to gain greater insights into the volcanism that created the samples in the first place.
Chinese scientists have already discovered that the basaltic material in the Chang'e 5 sample is substantially younger than the volcanic samples collected by Apollo, by billions of years. This tells us that the moon was volcanically active for much longer than scientists had realized — perhaps as recently as 120 million years ago.
Meanwhile, in the United Kingdom, Anand's team will heat some of their 60 milligram sample to 2,550 degrees Fahrenheit (1,400 degrees Celsius) to extract noble gases such as argon and krypton, as well as carbon, nitrogen and oxygen, to provide more data about the history of those elements in the solar system.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pacific spiny lumpsucker: The adorable little fish with a weird suction cup resembling human teeth
Pacific spiny lumpsucker: The adorable little fish with a weird suction cup resembling human teeth

Yahoo

timean hour ago

  • Yahoo

Pacific spiny lumpsucker: The adorable little fish with a weird suction cup resembling human teeth

When you buy through links on our articles, Future and its syndication partners may earn a commission. QUICK FACTS Name: Pacific spiny lumpsucker (Eumicrotremus orbis) Where it lives: Northern Pacific, from Washington to Japan and north into the Bering Sea What it eats: Small fish, jellyfish, ctenophores, crustaceans, polychaetes Pacific spiny lumpsuckers' tiny, plump bodies and adorable appearance make them essentially wild kawaii. They are awkward swimmers, so to avoid being swept off by currents in their coastal homes, their pelvic fin has evolved to act as a suction cup, enabling them to anchor themselves to a stable surface. At just 1 to 3 inches (2.5 to 7.6 centimeters) long, they are the smallest of the 27 species of lumpsuckers, also called lumpfish, some of which can grow as long as two feet (61 cm). Lumpfish are in the same order, Scorpaeniformes, as blobfish, sea robins and stonefish. Pacific spiny lumpsuckers are small, globular fish with extra-small fins which they flap wildly to get around. It makes them able-but-awkward swimmers. Living close to the coast and facing the pulls of tides and strong currents, their pelvic fins are fused to form a surprisingly strong sucker disc which lets them attach to rocks, coral or kelp, and, in aquariums, even to the side of a tank. These sucker discs are a bit fearsome to look at from the underside – like a lamprey with a circle of human teeth. That's because, like our teeth, those of the Pacific spiny lumpsucker are made from enamel. The disc also emits a green and yellow glow — though the reasons for this are not known. Males are usually red (see 'concerned strawberries') and glow red under ultraviolet light, while females are usually green to brown and don't glow under UV rays. RELATED STORIES —Pelican eel: The midnight zone 'gulper' with a giant mouth to swallow animals bigger than itself —Pearlfish: The eel-like fish that lives up a sea cucumber's butt —Pigbutt worm: The deep-sea 'mystery blob' with the rump of a pig and a ballooned belly When it's time to reproduce, only the males settle down. They stake out a territory, usually a shallow depression in warmer water where the females lay their eggs. The male fertilizes them and then she leaves and he tends to and guards the next generation from lumpsuckers don't yet have a defense the adults have — rows of enamel bumps called odontodes covering their bodies, including that toothy-looking circle on their undersides. Eventually, they will grow odontodes in spiral rows all around their bodies to protect them against predators and collisions with rough surfaces.

SpaceX launches satellite for SiriusXM from Florida
SpaceX launches satellite for SiriusXM from Florida

Yahoo

time2 hours ago

  • Yahoo

SpaceX launches satellite for SiriusXM from Florida

June 7 (UPI) -- SpaceX launched SiriusXM's second new satellite into orbit from Florida early Saturday after five delays. The Falcon 9 lifted off at 12:54 a.m. EDT from pad 40 at Cape Canaveral Space Force Station. About 8 1/2 minutes later, the first-stage booster landed on SpaceX's drone ship "A Shortfall of Gravitas" in the Atlantic Ocean. It was the eighth flight for the Falcon 9 booster, including a Crew-9 and three Starlink missions. After 33 minutes, the 4,100-pound SXM-10 satellite was sent to a geosynchronous transfer orbit high above Earth, meaning it is synchronous with the planet's rotation. It was SpaceX's 48th orbital rocket launch this year from Cape Canaveral or nearby Kennedy Space Center. Counting the California launch site, there have been 69 Falcon 9 missions with 51 involving Starlink in 2025, reported. Earlier Friday, there was a lightning warning for the area, Florida Today reported. On Dec. 5, SpaceX launched the SXM-9 for SiriusXM. In all, SiriusXM will have seven functional satellites with SXM-10's availability. Maxar Space Systems built both satellites, which beam radio and internet programming for SiriusXM's subscribers in the United States, Canada and Puerto Rico. The SXM-10 satellite arrived at Cape Canaveral on May 15. "This latest satellite marks another milestone in our over two-decade partnership with SiriusXM, supporting the continued evolution of their satellite radio network," Maxar posted on X. SiriusXM is planning to launch two more satellites. "SiriusXM is committed to cutting-edge technology and enhancing the proprietary satellite delivery systems that help power our audio entertainment and information service offerings," Bridget Neville, SiriusXM's senior vice president and general manager of Signal Distribution Engineering said in December, adding they "will strengthen the health of our satellite fleet for decades to come and allow our team to continue innovating far into the future." The next Falcon 9 launch of Starlink satellites is scheduled for 6:34 a.m. PDT Sunday from Vandenberg Space Force Base's pad 4E in California. In Florida, SpaceX next plans to launch the fourth Axiom private astronaut mission to the International Space Station. The Dragon mission is scheduled for 8:22 a.m. Tuesday from Kennedy Space Center pad 39A in conjunction with NASA. Axiom Space and SpaceX are planning coverage to start at 6:15 a.m. and NASA at 7:25 a.m. Peggy Whitson, a former NASA astronaut and director of human spaceflight at Axiom Space, will command the commercial mission.

Menopause drug might prevent breast cancer and treat hot flashes, research finds
Menopause drug might prevent breast cancer and treat hot flashes, research finds

New York Post

time3 hours ago

  • New York Post

Menopause drug might prevent breast cancer and treat hot flashes, research finds

A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, 'significantly reduced' breast tissue cell growth, which is a major indicator of cancer progression. Advertisement A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern. This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer. The women were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Duavee is a conjugated estrogen/bazedoxifene (CE/BZA) drug, which combines estrogen with another medication that minimizes the potential harmful side effects of the hormone. Advertisement 'The key takeaway from the study is that CE/BZA slows the growth (proliferation) of cells in milk ducts of DCIS that expressed the estrogen receptor significantly more than placebo,' Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, told Fox News Digital. 5 New research from Northwestern University found that the drug Duavee 'significantly reduced' breast tissue cell growth, a major indicator of cancer progression. Marko Geber – Another major finding is that the quality of life did not differ significantly between the two groups, but patients who took the CE/BZA reported fewer hot flashes during the study, she noted. 'This would be expected, as the drug is FDA-approved to treat hot flashes.' Advertisement Kulkarni presented the study last week at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. 5 The women in the study were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Gorodenkoff – 5 Those who took the drug reported fewer hot flashes during the study. fizkes – The findings are preliminary and have not yet been published in a medical journal. Advertisement 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' said the doctor, who is also a Northwestern Medicine breast surgeon. Women who face a higher risk of breast cancer — including those who have experienced 'high-risk lesions' — and who also have menopausal symptoms are most likely to benefit from the drug, according to Kulkarni. 'These women are typically advised against standard hormone therapies, leaving them with few menopausal treatment options,' the release stated. Study limitations The researchers said they are 'encouraged' by these early results, but more research is required before the medication can be considered for approval as a breast cancer prevention mechanism. 'Our findings suggest that CE/BZA may prevent breast cancer, but larger studies with several years of follow-up are needed before we would know this for sure,' Kulkarni told Fox News Digital. Dr. Sheheryar Kabraji, chief of breast medicine at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, was not involved in the study but commented on the findings. 5 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' Dr. Swati Kulkarni said. sarayutsridee – Advertisement 'While intriguing, this study is highly preliminary, and more research will be needed before we can conclude that conjugated estrogen/bazedoxifene (CD/BZA), a form of the hormone estrogen commonly prescribed to address symptoms of menopause, prevents invasive breast cancer or is effective at reducing cancer risk,' he told Fox News Digital. Kabraji also noted that the study focused on reducing levels of one specific protein, 'which does not always predict reduced recurrence of breast cancer.' 'This study did not directly show that CE/BZA treatment reduces the risk of DCIS recurrence or development of invasive cancer,' he noted. 5 According to Kulkarni,'larger studies with several years of follow-up are needed' to confirm that the drug prevents breast cancer. Science RF – Advertisement 'Importantly, however, patients who received this therapy experienced no worsening of quality of life, and saw improvement in vasomotor symptoms, such as hot flashes. If found to be effective in preventing breast cancer, CE/BZA is likely to have fewer side effects than current medications used for breast cancer prevention.' Lead researcher Kulkarni emphasized that this medication is not for the treatment of invasive breast cancer or DCIS. 'Right now, we can say that women who are concerned about their risk of developing breast cancer can consider this medication to treat their menopausal symptoms,' she added.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store